QHL-1618

• Description:

  QHL-1618 is a tumor microenvironment-activated drug conjugate. QHL-1618 inhibits the tumor growth in various tumor models, such as HT-1080 xenograft, CT-26 xenograft[1].

• UNSPSC:

  12352211

• Target:

  Others

• Related Pathways:

  Others

• Field of Research:

  Cancer

• Smiles:

  O=C(C=C1)N(C1=O)CCC(N[C@@H](CCC(NCCOCCOCCOCCOCCOCCOCCOCCOC)=O)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](CC(N)=O)C(NCOCC(N[C@H]2CCC3=C4C2=C5C(C(N6C5)=CC([C@@](O)(CC)C(OC7)=O)=C7C6=O)=NC4=CC(F)=C3C)=O)=O)=O)=O)=O)=O

• Molecular Formula:

  C66H90FN11O23

• Molecular Weight:

  1424.48

• References & Citations:

  [1]Yuan Liu, et al. Tumor microenvironment-activated drug conjugate and antibody-drug conjugate. Patent. WO2025130991A1

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  3106015-71-5